. Sh-swerdlow, WHO classification of tumours of haematopoiectic and lymphoid tissues. 2017 e éd. WHO classification of tumours

H. Stein, D. Y. Mason, J. Gerdes, N. O'connor, J. Wainscoat et al., The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells, Blood. oct, vol.66, issue.4, pp.848-58, 1985.

C. A. Van-der-weyden, S. A. Pileri, A. L. Feldman, J. Whisstock, and H. M. Prince, Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions, Blood Cancer J. 8 sept, vol.7, issue.9, p.603, 2017.

W. Kempf, A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders, Semin Diagn Pathol. janv, vol.34, issue.1, pp.22-35, 2017.

I. Wieser, M. T. Tetzlaff, C. A. Torres-cabala, and M. Duvic, Primary cutaneous CD30(+) lymphoproliferative disorders, J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. août, vol.14, issue.8, pp.767-82, 2016.

W. L. Macaulay, Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant, Arch Dermatol. janv, vol.97, issue.1, pp.23-30, 1968.

T. Nijsten, C. Curiel-lewandrowski, and M. E. Kadin, Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases, Arch Dermatol. mars, vol.140, issue.3, pp.306-318, 2004.

M. Duvic, CD30+ neoplasms of the skin, Curr Hematol Malig Rep. déc, vol.6, issue.4, pp.245-50, 2011.

M. W. Bekkenk, F. A. Geelen, P. C. Van-voorst-vader, F. Heule, M. L. Geerts et al., Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment, Blood. 15 juin, vol.95, issue.12, pp.3653-61, 2000.

J. Lin, W. Shiau, C. Lu, C. Tsai, W. Wong et al., Lymphomatoid papulosis: a clinical and histopathologic review and follow-up study of 34 cases in Taiwan, Dermatol Sin. mars, vol.29, issue.1, pp.8-12, 2011.

S. H. Swerdlow, E. Campo, S. A. Pileri, N. L. Harris, H. Stein et al., The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.19, issue.20, pp.2375-90, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800015

E. Shabrawi-caelen, L. Kerl, H. Cerroni, and L. , Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C, Arch Dermatol. avr, vol.140, issue.4, pp.441-448, 2004.

A. Saggini, A. Gulia, Z. Argenyi, R. Fink-puches, A. Lissia et al., A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases, Am J Surg Pathol. août, vol.34, issue.8, pp.1168-75, 2010.

W. Kempf, D. V. Kazakov, L. Schärer, A. Rütten, T. Mentzel et al., Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas, Am J Surg Pathol. janv, vol.37, issue.1, pp.1-13, 2013.

W. Kempf, D. V. Kazakov, H. Baumgartner, and H. Kutzner, Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings, J Am Acad Dermatol. mai, vol.68, issue.5, pp.809-825, 2013.

S. Morimura, M. Sugaya, Z. Tamaki, T. Takekoshi, and S. Sato, Lymphomatoid papulosis showing ?? T-cell phenotype, Acta Derm Venereol, vol.91, issue.6, pp.712-715, 2011.

L. J. Karai, M. E. Kadin, E. D. Hsi, J. C. Sluzevich, R. P. Ketterling et al., Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis, Am J Surg Pathol. août, vol.37, issue.8, pp.1173-81, 2013.

M. Steinhoff, M. Hummel, I. Anagnostopoulos, P. Kaudewitz, V. Seitz et al., Singlecell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal Tcell origin, Blood. 15 juill, vol.100, issue.2, pp.578-84, 2002.

A. M. Stowman, L. Hsia, W. A. Kanner, M. S. Mahadevan, G. C. Bullock et al., Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature, Int J Dermatol. févr, vol.55, issue.2, pp.62-71, 2016.

A. Chott, E. C. Vonderheid, S. Olbricht, N. N. Miao, S. P. Balk et al., The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis, J Invest Dermatol. avr, vol.106, issue.4, pp.696-700, 1996.

M. M. De-la-garza-bravo, K. P. Patel, S. Loghavi, J. L. Curry, C. A. Torres-cabala et al., Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin, Hum Pathol. avr, vol.46, issue.4, pp.558-69, 2015.

G. Dawn, A. Morrison, R. Morton, D. Bilsland, and R. Jackson, Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis, Clin Exp Dermatol, vol.28, issue.6, pp.620-624, 2003.

F. C. Eberle, J. Y. Song, L. Xi, M. Raffeld, N. L. Harris et al., Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma, Am J Surg Pathol. mai, vol.36, issue.5, pp.716-741, 2012.

J. Wechsler, Pathologie cutanée tumorale. 2ème édition, p.66, 2016.

N. Cordel, B. Tressières, D. 'incan, M. Machet, L. Grange et al., Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis, The Oncologist. janv, vol.21, issue.1, pp.76-83, 2016.

J. H. Kunishige, H. Mcdonald, G. Alvarez, M. Johnson, V. Prieto et al., Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients, Clin Exp Dermatol. juill, vol.34, issue.5, pp.576-81, 2009.

W. Kempf, K. Pfaltz, M. H. Vermeer, A. Cozzio, P. L. Ortiz-romero et al., ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma, Blood, vol.118, issue.15, pp.4024-4059, 2011.

M. Beylot-barry, O. Dereure, B. Vergier, S. Barete, L. Laroche et al., Prise en charge des lymphomes T cutanés : recommandations du Groupe français d'étude des lymphomes cutanés, Ann Dermatol Vénéréologie, vol.137, issue.10, pp.611-632, 2010.

D. J. Lewis, R. Talpur, A. O. Huen, M. T. Tetzlaff, and M. Duvic, Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results, JAMA Dermatol. 1 déc, vol.153, issue.12, p.1302, 2017.

N. Booken, S. Goerdt, and C. Klemke, Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry, J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. mai, vol.10, issue.5, pp.331-340, 2012.

D. A. Wada, M. E. Law, E. D. Hsi, D. J. Dicaudo, L. Ma et al., Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies, Mod Pathol Off J U S Can Acad Pathol Inc. avr, vol.24, issue.4, pp.596-605, 2011.

C. Droc, H. D. Cualing, and M. E. Kadin, Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin, Cancer Control J Moffitt Cancer Cent. avr, vol.14, issue.2, pp.124-156, 2007.
DOI : 10.1177/107327480701400205

B. Falini, S. Pileri, P. L. Zinzani, A. Carbone, V. Zagonel et al., ALK+ lymphoma: clinico-pathological findings and outcome, Blood. 15 avr, vol.93, issue.8, pp.2697-706, 1999.

C. Querfeld, I. Khan, B. Mahon, B. P. Nelson, and S. T. Rosen, Evens AM. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options, Oncol Williston Park N. juin, vol.24, issue.7, pp.574-87, 2010.

M. Duvic, M. T. Tetzlaff, P. Gangar, A. L. Clos, D. Sui et al., Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis, J Clin Oncol Off J Am Soc Clin Oncol, vol.33, issue.32, pp.3759-65, 2015.

, A clinical evaluation of the International Lymphoma Study Group classification of nonHodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project, Blood. 1 juin, vol.89, issue.11, pp.3909-3927, 1997.

J. Mora, D. A. Filippa, H. T. Thaler, T. Polyak, M. L. Cranor et al., Large cell non-Hodgkin lymphoma of childhood: Analysis of 78 consecutive patients enrolled in 2 consecutive protocols at the Memorial Sloan-Kettering Cancer Center, Cancer. 1 janv, vol.88, issue.1, pp.186-97, 2000.

E. S. Jaffe, D. A. Arber, E. Campo, N. L. Harris, L. Quintanilla-martinez et al., , 2017.

S. Ghorbian, Molecular pathology diagnosis of diffuse large B cell lymphoma using BIOMED-2 clonal gene rearrangements, Ann Diagn Pathol. août, vol.29, pp.28-31, 2017.

A. A. Alizadeh, M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature. 3 févr, vol.403, issue.6769, pp.503-514, 2000.
DOI : 10.1038/35000501

A. Rosenwald, G. Wright, W. C. Chan, J. M. Connors, E. Campo et al., The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma, N Engl J Med. 20 juin, vol.346, issue.25, pp.1937-1984, 2002.

A. Behdad and N. G. Bailey, Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas, Surg Pathol Clin. mars, vol.9, issue.1, pp.41-54, 2016.
DOI : 10.1016/j.path.2015.09.008

C. Beham-schmid, Aggressive lymphoma 2016: revision of the WHO classification, Memo, vol.10, issue.4, pp.248-54, 2017.

M. Bernard, R. Gressin, F. Lefrère, B. Drénou, B. Branger et al., Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype, Leukemia, vol.15, issue.11, pp.1785-91, 2001.

J. Van-dongen, A. W. Langerak, M. Brüggemann, P. Evans, .. S. Hummel et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia. déc, vol.17, issue.12, pp.2257-317, 2003.

M. Bottaro, E. Berti, A. Biondi, N. Migone, and L. Crosti, Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas, Blood. 1 juin, vol.83, issue.11, pp.3271-3279, 1994.

M. Kneba, I. Bolz, B. Linke, and W. Hiddemann, Analysis of rearranged T-cell receptor betachain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis, Blood, vol.86, issue.10, pp.3930-3937, 1995.

K. J. Savage, N. L. Harris, J. M. Vose, F. Ullrich, E. S. Jaffe et al., ALK-anaplastic largecell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project, Blood. 15 juin, vol.111, issue.12, pp.5496-504, 2008.
DOI : 10.1182/blood-2008-01-134270

URL : http://www.bloodjournal.org/content/111/12/5496.full.pdf

M. Marschalkó, N. Eros, P. Holló, J. Hársing, G. Bottlik et al., Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration, Am J Dermatopathol, vol.32, issue.7, pp.708-720, 2010.